Ikena Oncology News

Ikena Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(2.771%),Abigail P. Johnson(2.771%)

Mar 11 08:22 ET

Ikena Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Germa Caroline

Mar 5 16:09 ET

Ikena Oncology | 3: Initial statement of beneficial ownership of securities-Officer Germa Caroline

Mar 5 16:05 ET

Ikena Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(0.4%),Citadel Advisors LLC(0.3%), etc.

Feb 14 17:02 ET

Ikena Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Feb 14 16:56 ET

Ikena Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF Partners L.P.(9.9%),BVF Inc.(9.9%), etc.

Feb 14 09:52 ET

Ikena Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(9.545%),Abigail P. Johnson(9.545%)

Feb 9 09:21 ET

Ikena Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Ecsedy Jeffrey

Feb 2 17:17 ET

Ikena Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Manfredi Mark

Feb 2 17:13 ET

Ikena Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Marango Jotin

Feb 2 17:13 ET

Ikena Oncology | SC 13G: Statement of acquisition of beneficial ownership by individuals-Gilead Sciences, Inc.(6.7%)

Oct 19, 2023 15:33 ET

Ikena Oncology | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Bonita David P

Sep 21, 2023 17:04 ET

Ikena Oncology | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director ORBIMED ADVISORS LLC

Sep 21, 2023 17:02 ET

Ikena Oncology | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(5.2%),OrbiMed Capital GP VI LLC(5.0%), etc.

Sep 21, 2023 16:52 ET

Ikena Oncology | 4: Statement of changes in beneficial ownership of securities-Director ORBIMED ADVISORS LLC

Sep 14, 2023 21:22 ET

Ikena Oncology | 4: Statement of changes in beneficial ownership of securities-Director Bonita David P

Sep 14, 2023 21:17 ET

Ikena Oncology | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(5.5%),OrbiMed Capital GP VI LLC(5.3%), etc.

Sep 14, 2023 16:21 ET

Ikena Oncology | D: Filing D

Aug 18, 2023 16:03 ET

Ikena Oncology | 4: Statement of changes in beneficial ownership of securities-Director Dukes Iain D.

Jun 13, 2023 16:30 ET

Ikena Oncology | 4: Statement of changes in beneficial ownership of securities-Director Hughes Owen

Jun 13, 2023 16:30 ET